Chronic Myelomonocytic Leukemia-1 — Trials

Chronic Myelomonocytic Leukemia-1 — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03682029	Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies(EVITA)	unknown	N/A	109	Rigshospitalet, DenmarkOTHER	2	Apr 17, 2024	clinicaltrials

Data updated 22 days agoSource updated Apr 17, 2024source: clinicaltrials